XFXuancheng Fu

Xuancheng Fu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Xuancheng Fu has a total of 45 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A photosensitizer-drug conjugate for synergistic photodynamic therapy and photo-triggered camptothecin release

    by Bowen Xu, Xuancheng Fu, Zhiwei Huang, Cijun Zhang, Xiaoran Hu

    Red-light-responsive nanoparticles enable singlet oxygen-mediated thioketal cleavage and controlled camptothecin release for synergistic chemo–photodynamic therapy.

  • Open Access

    A Noncovalent Click‐to‐Release Strategy to Control Bond Cleavage and Prodrug Activation

    by Xuancheng Fu, Bowen Xu, Suman Maity, Michelle Wu, Luke G. Westbrook, James H. Henderson, Yaoying Wu, Katie A. Edwards, Atanu Acharya, Xiaoran Hu

    Click‐to‐release chemistry enables bioorthogonal bond cleavage and controlled release via a click‐type ligation reaction serving as both the trigger and means of localization. Extending this concept beyond covalent ligation reactions, we introduce a noncovalent click‐to‐release strategy based on cucurbit[7]uril‐adamantane (CB‐Ad) association. The CB host molecule forms a pre‐assembled host‐guest complex with a self‐immolative guest (SIG) SIG1, where the masked SIG remains inert. Introduction of a high‐affinity guest Ad initiates the CB‐Ad noncovalent click reaction, displacing SIG1 and triggering its self‐immolation and cargo release. As a proof‐of‐concept, we used a prototype prodrug SIG2 to demonstrate our strategy's potential for controlled therapeutic release, effectively regulating the photodynamic cell killing in vitro. This noncovalent click‐to‐release approach broadens the structural and functional scope of bioorthogonal cleavage strategies with promising implications for stimuli‐responsive materials and biomedical applications.


  • Open Access

    A Noncovalent Click‐to‐Release Strategy to Control Bond Cleavage and Prodrug Activation

    by Xuancheng Fu, Bowen Xu, Suman Maity, Michelle Wu, Luke G. Westbrook, James H. Henderson, Yaoying Wu, Katie A. Edwards, Atanu Acharya, Xiaoran Hu

    Click‐to‐release chemistry enables bioorthogonal bond cleavage and controlled release via a click‐type ligation reaction serving as both the trigger and means of localization. Extending this concept beyond covalent ligation reactions, we introduce a noncovalent click‐to‐release strategy based on cucurbit[7]uril‐adamantane (CB‐Ad) association. The CB host molecule forms a pre‐assembled host‐guest complex with a self‐immolative guest (SIG) SIG1, where the masked SIG remains inert. Introduction of a high‐affinity guest Ad initiates the CB‐Ad noncovalent click reaction, displacing SIG1 and triggering its self‐immolation and cargo release. As a proof‐of‐concept, we used a prototype prodrug SIG2 to demonstrate our strategy's potential for controlled therapeutic release, effectively regulating the photodynamic cell killing in vitro. This noncovalent click‐to‐release approach broadens the structural and functional scope of bioorthogonal cleavage strategies with promising implications for stimuli‐responsive materials and biomedical applications.


  • Open Access

    Ultrasound-triggered prodrug activation via sonochemically induced cleavage of a 3,5-dihydroxybenzyl carbamate scaffold

    by Xuancheng Fu, Bowen Xu, Hirusha Liyanage, Cijun Zhang, Warren F. Kincaid, Amber L. Ford, Luke G. Westbrook, Seth D. Brown, Tatum DeMarco, James L. Hougland, et al.

    Deep-penetrating low-intensity therapeutic ultrasound (LITUS) induces the cleavage of a 3,5-dihydroxybenzyl carbamate (DHBC) prodrug scaffold via a sonochemical activation mechanism, enabling spatiotemporally controlled drug release.


  • A biophotonic device based on a conjugated polymer and a macrophage-laden hydrogel for triggering immunotherapy

    by Zhiwen Yang, Qi Shen, Longjiang Xing, Xuancheng Fu, Zhipeng Qiu, Hongping Xiang, Yiming Huang, Fengting Lv, Haotian Bai, Yanping Huo, et al.

    A biophotonic device is fabricated for employing a flexible OLED to excite conjugated polymer PPV in a macrophage (M0)-laden 3D printed hydrogel, resulting in the generation of ROS and subsequent M1 macrophage polarization for tumor immunotherapy.


  • Simultaneous and visual detection of multiple dopes by an aptamer/AuNPs sensor

    by Xuancheng Fu, Miaomiao Gou, Yong Zhang, Hao Su, Haotian Zhao, Chang Liu, Jing Han

    Point-of-care testing (POCT) has exhibited broad applications owing to its rapid on-site detection capability under resource-limited conditions. However, most POCT sensors can only detect single substance in each assay, which does not meet the requirements of simultaneous multi-components analysis in most cases. Herein, we report a simple POCT sensor for simultaneously analyzing multiple dopes in minutes. This sensor is composed of gold nanoparticles (AuNPs) assembled with several aptamers. The coating of aptamers on the surface of AuNPs prevents nanoparticles from aggregating in a high-salt environment. In the presence of dopes, the stronger interaction between aptamers and dopes induces the stripping of aptamers from the AuNPs, following the AuNP aggregation in high-salt conditions which further results in a significant color change of the solution. Introducing multi-aptamers in a suitable ratio, we achieved the simultaneous and visual detection of three dopes in one sensor. The linear ranges were determined as 0.1–10 μM for dexamethasone, 0.5–100 μM for salbutamol, and 0.05–10 μM for ractopamine, with detection limits of 53 nM, 130 nM, and 11 nM for the above targets, respectively. The feasibility of this method in practical application was also confirmed via blood and urine samples. Compared with traditional targeting single dopes POCT sensors, this multi-dopes detecting sensor better matches the real demands required during dopes testing. Meanwhile, this label-free approach for simultaneous multi-component detection broadens the application of POCT towards simultaneous multi-target analysis.


  • Selective Fluorescence Imaging of Cancer Cells Based on ROS‐Triggered Intracellular Cross‐Linking of Artificial Enzyme

    by Yufei Di, Endong Zhang, Zhiwen Yang, Qi Shen, Xuancheng Fu, Gang Song, Chuanwei Zhu, Haotian Bai, Yiming Huang, Fengting Lv, et al.

    Inside living cells, regulation of catalytic activity of artificial enzymes remains challenging due to issues such as biocompatibility, efficiency, and stability of the catalyst, by which the practical applications of artificial enzymes have been severely hindered. Here, an artificial enzyme, PTT‐SGH, with responsiveness to reactive oxygen species (ROS), was obtained by introducing a catalytic histidine residue to pentaerythritol tetra(3‐mercaptopropionate) (PTT). The artificial enzyme formed large aggregates in cells via the intracellular ROS‐mediated oxidation of thiol groups. The process was significantly facilitated in tumor cells because of the higher ROS concentration in the tumor microenvironment. The catalytic activity of this artificial enzyme was intensively enhanced through deprotonation of cross‐linked PTT‐SGH, which showed typical esterase activities. Selective fluorescence imaging of tumor cells was achieved using the artificial enzyme to trigger the cleavage of the ester bond of the caged fluorophore inside living cells.


  • Selective Fluorescence Imaging of Cancer Cells Based on ROS‐Triggered Intracellular Cross‐Linking of Artificial Enzyme

    by Yufei Di, Endong Zhang, Zhiwen Yang, Qi Shen, Xuancheng Fu, Gang Song, Chuanwei Zhu, Haotian Bai, Yiming Huang, Fengting Lv, et al.

    Inside living cells, regulation of catalytic activity of artificial enzymes remains challenging due to issues such as biocompatibility, efficiency, and stability of the catalyst, by which the practical applications of artificial enzymes have been severely hindered. Here, an artificial enzyme, PTT‐SGH, with responsiveness to reactive oxygen species (ROS), was obtained by introducing a catalytic histidine residue to pentaerythritol tetra(3‐mercaptopropionate) (PTT). The artificial enzyme formed large aggregates in cells via the intracellular ROS‐mediated oxidation of thiol groups. The process was significantly facilitated in tumor cells because of the higher ROS concentration in the tumor microenvironment. The catalytic activity of this artificial enzyme was intensively enhanced through deprotonation of cross‐linked PTT‐SGH, which showed typical esterase activities. Selective fluorescence imaging of tumor cells was achieved using the artificial enzyme to trigger the cleavage of the ester bond of the caged fluorophore inside living cells.


  • Conjugated Polymer Nanomaterials for Phototherapy of Cancer

    by Xuancheng Fu, Haotian Bai, Fengting Lyu, Libing Liu, Shu Wang